Vimab Group AB (FRA:NM4) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vimab Group AB Change In Payables And Accrued Expense?

Vimab Group AB's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was €0.00 Mil. It means Vimab Group AB's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Sep. 2023 .

Vimab Group AB's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Vimab Group AB's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .

Vimab Group AB Change In Payables And Accrued Expense Historical Data

The historical data trend for Vimab Group AB's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimab Group AB Change In Payables And Accrued Expense Chart

Vimab Group AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Vimab Group AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Vimab Group AB Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Vimab Group AB Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Vimab Group AB's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Vimab Group AB (FRA:NM4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Vimab Group AB (FRA:NM4) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

VIMAB:Sweden

Address

Malmskillnadsgatan 40A, Stockholm, SWE, 111 57

Website

https://www.vimabgroup.com

Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.

Vimab Group AB (FRA:NM4) Headlines

No Headlines